Literature DB >> 27502869

Understanding physician-level barriers to the use of individualized risk estimates in percutaneous coronary intervention.

Carole Decker1, Linda Garavalia2, Brian Garavalia3, Elizabeth Gialde3, Robert W Yeh4, John Spertus1, Adnan K Chhatriwalla5.   

Abstract

BACKGROUND: The foundation of precision medicine is the ability to tailor therapy based upon the expected risks and benefits of treatment for each individual patient. In a prior study, we implemented a software platform, ePRISM, to execute validated risk-stratification models for patients undergoing percutaneous coronary intervention and found substantial variability in the use of the personalized estimates to tailor care. A better understanding of physicians' perspectives about the use of individualized risk-estimates is needed to overcome barriers to their adoption.
METHODS: In a qualitative research study, we conducted interviews, in-person or by telephone, with 27 physicians at 8 centers that used ePRISM until thematic saturation occurred. Data were coded using descriptive content analyses.
RESULTS: Three major themes emerged among physicians who did not use ePRISM to support decision making: (1) "Experience versus Evidence," physicians' preference to rely upon personal experience and subjective assessments rather than objective risk estimates; (2) "Omission of Therapy," the perception that the use of risk models leads to unacceptable omission of potentially beneficial therapy; and (3) "Unnecessary Information," the opinion that information derived from risk models is not needed because physicians' decision making is already sound and they already know the information.
CONCLUSIONS: Barriers to the use of risk models in clinical practice include physicians' perceptions that their experience is sufficient, that models may lead to omission of therapy in patients that may benefit from therapy, and that they already provide good care. Anticipating and overcoming these barriers may improve the adoption of precision medicine.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27502869      PMCID: PMC5340532          DOI: 10.1016/j.ahj.2016.03.027

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  40 in total

Review 1.  Qualitative research in health care. Analysing qualitative data.

Authors:  C Pope; S Ziebland; N Mays
Journal:  BMJ       Date:  2000-01-08

Review 2.  Clinical versus actuarial judgment.

Authors:  R M Dawes; D Faust; P E Meehl
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

3.  The ethical implications of Paul Meehl's work on comparing clinical versus actuarial prediction methods.

Authors:  Robyn M Dawes
Journal:  J Clin Psychol       Date:  2005-10

4.  Perceived risk of ischemic and bleeding events in acute coronary syndromes.

Authors:  Derek P Chew; Ge Junbo; William Parsonage; Prafulla Kerkar; Vitaly A Sulimov; Matthew Horsfall; Sue Mattchoss
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-05-07

Review 5.  Real-time decision support to guide percutaneous coronary intervention bleeding avoidance strategies effectively changes practice patterns.

Authors:  Craig E Strauss; Brandon R Porten; Ivan J Chavez; Ross F Garberich; Jeffrey W Chambers; Kenneth W Baran; Anil K Poulose; Timothy D Henry
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-11-04

6.  Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status.

Authors:  Amit P Amin; Alok Bachuwar; Kimberly J Reid; Adnan K Chhatriwalla; Adam C Salisbury; Robert W Yeh; Mikhail Kosiborod; Tracy Y Wang; Karen P Alexander; Kensey Gosch; David J Cohen; John A Spertus; Richard G Bach
Journal:  J Am Coll Cardiol       Date:  2013-03-26       Impact factor: 24.094

7.  Pre-procedural estimate of individualized bleeding risk impacts physicians' utilization of bivalirudin during percutaneous coronary intervention.

Authors:  Seshu C Rao; Adnan K Chhatriwalla; Kevin F Kennedy; Carole J Decker; Elizabeth Gialde; John A Spertus; Steven P Marso
Journal:  J Am Coll Cardiol       Date:  2013-03-07       Impact factor: 24.094

8.  Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease.

Authors:  Grace A Lin; R Adams Dudley; Rita F Redberg
Journal:  Arch Intern Med       Date:  2007 Aug 13-27

9.  Predicting outcome in coronary disease. Statistical models versus expert clinicians.

Authors:  K L Lee; D B Pryor; F E Harrell; R M Califf; V S Behar; W L Floyd; J J Morris; R A Waugh; R E Whalen; R A Rosati
Journal:  Am J Med       Date:  1986-04       Impact factor: 4.965

10.  Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals' perceptions.

Authors:  Karine Gravel; France Légaré; Ian D Graham
Journal:  Implement Sci       Date:  2006-08-09       Impact factor: 7.327

View more
  8 in total

Review 1.  Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.

Authors:  David M Kent; Ewout Steyerberg; David van Klaveren
Journal:  BMJ       Date:  2018-12-10

2.  Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design.

Authors:  Adnan K Chhatriwalla; Carole Decker; Elizabeth Gialde; Delwyn Catley; Kathy Goggin; Katie Jaschke; Philip Jones; Dave deBronkart; Tony Sun; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-02

3.  The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.

Authors:  David M Kent; David van Klaveren; Jessica K Paulus; Ralph D'Agostino; Steve Goodman; Rodney Hayward; John P A Ioannidis; Bray Patrick-Lake; Sally Morton; Michael Pencina; Gowri Raman; Joseph S Ross; Harry P Selker; Ravi Varadhan; Andrew Vickers; John B Wong; Ewout W Steyerberg
Journal:  Ann Intern Med       Date:  2019-11-12       Impact factor: 25.391

Review 4.  Palliative treatment of coronary "atherosclerotic cancer" by drug-eluting or bare-metal stents: From oculo-stenotic reflex period to age of precision medicine.

Authors:  Elif Hande Ozcan Cetin; Ozcan Ozeke; Erdogan Ilkay; Dursun Aras; Serkan Topaloglu; Zehra Golbasi; Sinan Aydogdu; Can Ozer
Journal:  Indian Heart J       Date:  2017-07-14

5.  Development and Evaluation of Novel Electronic Medical Record Tools For Avoiding Bleeding After Percutaneous Coronary Intervention.

Authors:  Joseph Ebinger; Timothy Henry; Sungjin Kim; Moira Inkelas; Susan Cheng; Teryl Nuckols
Journal:  J Am Heart Assoc       Date:  2019-11-11       Impact factor: 5.501

6.  Physicians' Views on Utilization of an Electronic Health Record-Embedded Calculator to Assess Risk for Venous Thromboembolism among Medical Inpatients: A Qualitative Study.

Authors:  Stephanie R Moss; Kathryn A Martinez; Cassandra Nathan; Elizabeth R Pfoh; Michael B Rothberg
Journal:  TH Open       Date:  2022-01-24

7.  The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement.

Authors:  David M Kent; Jessica K Paulus; David van Klaveren; Ralph D'Agostino; Steve Goodman; Rodney Hayward; John P A Ioannidis; Bray Patrick-Lake; Sally Morton; Michael Pencina; Gowri Raman; Joseph S Ross; Harry P Selker; Ravi Varadhan; Andrew Vickers; John B Wong; Ewout W Steyerberg
Journal:  Ann Intern Med       Date:  2019-11-12       Impact factor: 25.391

8.  Reversing the "Risk-Treatment Paradox" of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk-Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs.

Authors:  Amit P Amin; Samantha Miller; Brandon Rahn; Mary Caruso; Andrew Pierce; Katrine Sorensen; Howard Kurz; Alan Zajarias; Richard Bach; Jasvindar Singh; John M Lasala; Hemant Kulkarni; Patricia Crimmins-Reda
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.